Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome.

about

Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome.

Item

http://www.wikidata.org/entity/Q50255248

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interleukin-8 and nuclear fact ...... d in myelodysplastic syndrome.

@en

Interleukin-8 and nuclear fact ...... d in myelodysplastic syndrome.

@nl

type

Item

label

Interleukin-8 and nuclear fact ...... d in myelodysplastic syndrome.

@en

Interleukin-8 and nuclear fact ...... d in myelodysplastic syndrome.

@nl

prefLabel

Interleukin-8 and nuclear fact ...... d in myelodysplastic syndrome.

@en

Interleukin-8 and nuclear fact ...... d in myelodysplastic syndrome.

@nl

P1476

Interleukin-8 and nuclear fact ...... ed in myelodysplastic syndrome

@en

P2093

Anacélia Gomes de Matos

http://www.w3.org/2001/XMLSchema#string

Bruno Memória Okubo

http://www.w3.org/2001/XMLSchema#string

Daniela de Paula Borges

http://www.w3.org/2001/XMLSchema#string

Juliana Cordeiro de Sousa

http://www.w3.org/2001/XMLSchema#string

Marilena Facundo de Castro

http://www.w3.org/2001/XMLSchema#string

Maritza Cavalcante Barbosa

http://www.w3.org/2001/XMLSchema#string

Romélia Pinheiro Gonçalves

http://www.w3.org/2001/XMLSchema#string

Ronald Feitosa Pinheiro

http://www.w3.org/2001/XMLSchema#string

Silvia Maria Meira Magalhães

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Immune Mechanisms in Myelodysplastic Syndrome

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

Introduction to NF-kappaB: players, pathways, perspectives

Inflammation meets cancer, with NF-κB as the matchmaker

Myelodysplastic syndromes: Contemporary review and how we treat.

Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

Revised international prognostic scoring system for myelodysplastic syndromes.

P2888

s12032-017-1023-1

P304

168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-1023-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Howard Lopes Ribeiro

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28856536

http://www.w3.org/2001/XMLSchema#string